Gerd V.
- Country
- Belgium
- Department
- NA
Research Overview
- Effect of Orforglipron on Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease
- Efficacy and Safety of Eloralintide in Adults With Persistent Obesity or Overweight Treated With a Weekly Incretin: A Phase 3, Randomized, Placebo-Controlled Study
- Efficacy and Safety of Zenagamtide in Participants with Obesity: A Randomized Controlled Trial to Evaluate Weight Maintenance
Data & Insights
Has run more than one trial at 41 of 305 partner sites.
Specializations
Diabetes Management
This investigator specializes in the study of innovative treatments for Type 2 Diabetes Mellitus, with particular emphasis on novel therapeutic approaches for glycemic control.
- Advanced diabetes therapeutics
- Glucose metabolism regulation
- Diabetes treatment optimization
Their research explores emerging therapeutic options for improving diabetes management outcomes.
Cardiovascular Health
The investigator focuses on the intersection of cardiovascular health and diabetes, studying therapeutic interventions that address both conditions simultaneously.
- Cardiovascular risk management
- Cardiovascular outcomes
- Preventive cardiology
Their work examines therapeutic approaches for reducing cardiovascular complications in diabetes patients.
Comparative Medicine
The investigator conducts research comparing different therapeutic approaches in metabolic disease management, with a focus on evaluating treatment efficacy.
- Treatment comparison studies
- Clinical outcomes assessment
- Therapeutic effectiveness
Their research evaluates the relative benefits of different therapeutic options for metabolic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.